The relative importance of frailty, physical and cardiovascular function as exercise-modifiable predictors of falls in haemodialysis patients: a prospective cohort study.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
14 03 2020
Historique:
received: 21 10 2019
accepted: 05 03 2020
entrez: 15 3 2020
pubmed: 15 3 2020
medline: 22 6 2021
Statut: epublish

Résumé

Stage 5 chronic kidney disease (CKD-5) patients on haemodialysis (HD) are at high risk of accidental falls. Previous research has shown that frailty is one of the primary contributors to the increased risk of falling in this clinical population. However, HD patients often present with abnormalities of cardiovascular function such as baroreflex impairment and orthostatic dysregulation of blood pressure (BP) which may also be implicated in the aetiology of falling. Therefore, we aimed to explore the relative importance of frailty and cardiovascular function as potential exercise-modifiable predictors of falls in these patients. Ninety-three prevalent CKD-5 patients on HD from three Renal Units were recruited for this prospective cohort study, which was conducted between October 2015 and August 2018. At baseline, frailty status was assessed using the Fried's frailty phenotype, while physical function was evaluated through timed up and go (TUG), five repetitions chair sit-to-stand (CSTS-5), objectively measured physical activity, and maximal voluntary isometric strength. Baroreflex and haemodynamic function at rest and in response to a 60° head-up tilt test (HUT-60°) were also assessed by means of the Task Force Monitor. The number of falls experienced was recorded once a month during 12 months of follow-up. In univariate negative binomial regression analysis, frailty (RR: 4.10, 95%CI: 1.60-10.51, p = 0.003) and other physical function determinants were associated with a higher number of falls. In multivariate analysis however, only worse baroreflex function (RR: 0.96, 95%CI: 0.94-0.99, p = 0.004), and orthostatic decrements of BP to HUT-60° (RR: 0.93, 95%CI: 0.87-0.99, p = 0.033) remained significantly associated with a greater number of falls. Eighty falls were recorded during the study period and the majority of them (41.3%) were precipitated by dizziness symptoms, as reported by participants. This prospective study indicates that cardiovascular mechanisms implicated in the short-term regulation of BP showed a greater relative importance than frailty in predicting falls in CKD-5 patients on HD. A high number of falls appeared to be mediated by a degree of cardiovascular dysregulation, as evidenced by the predominance of self-reported dizziness symptoms. ClinicalTrials.gov (trial registration ID: NCT02392299; date of registration: March 18, 2015).

Sections du résumé

BACKGROUND
Stage 5 chronic kidney disease (CKD-5) patients on haemodialysis (HD) are at high risk of accidental falls. Previous research has shown that frailty is one of the primary contributors to the increased risk of falling in this clinical population. However, HD patients often present with abnormalities of cardiovascular function such as baroreflex impairment and orthostatic dysregulation of blood pressure (BP) which may also be implicated in the aetiology of falling. Therefore, we aimed to explore the relative importance of frailty and cardiovascular function as potential exercise-modifiable predictors of falls in these patients.
METHODS
Ninety-three prevalent CKD-5 patients on HD from three Renal Units were recruited for this prospective cohort study, which was conducted between October 2015 and August 2018. At baseline, frailty status was assessed using the Fried's frailty phenotype, while physical function was evaluated through timed up and go (TUG), five repetitions chair sit-to-stand (CSTS-5), objectively measured physical activity, and maximal voluntary isometric strength. Baroreflex and haemodynamic function at rest and in response to a 60° head-up tilt test (HUT-60°) were also assessed by means of the Task Force Monitor. The number of falls experienced was recorded once a month during 12 months of follow-up.
RESULTS
In univariate negative binomial regression analysis, frailty (RR: 4.10, 95%CI: 1.60-10.51, p = 0.003) and other physical function determinants were associated with a higher number of falls. In multivariate analysis however, only worse baroreflex function (RR: 0.96, 95%CI: 0.94-0.99, p = 0.004), and orthostatic decrements of BP to HUT-60° (RR: 0.93, 95%CI: 0.87-0.99, p = 0.033) remained significantly associated with a greater number of falls. Eighty falls were recorded during the study period and the majority of them (41.3%) were precipitated by dizziness symptoms, as reported by participants.
CONCLUSIONS
This prospective study indicates that cardiovascular mechanisms implicated in the short-term regulation of BP showed a greater relative importance than frailty in predicting falls in CKD-5 patients on HD. A high number of falls appeared to be mediated by a degree of cardiovascular dysregulation, as evidenced by the predominance of self-reported dizziness symptoms.
TRIAL REGISTRATION
ClinicalTrials.gov (trial registration ID: NCT02392299; date of registration: March 18, 2015).

Identifiants

pubmed: 32169050
doi: 10.1186/s12882-020-01759-z
pii: 10.1186/s12882-020-01759-z
pmc: PMC7071740
doi:

Banques de données

ClinicalTrials.gov
['NCT02392299']

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

99

Subventions

Organisme : British Kidney Patient Association - British Renal Society
ID : 16-003
Pays : International

Références

Nephrol Dial Transplant. 2008 Apr;23(4):1396-400
pubmed: 18057068
Br J Anaesth. 2010 Sep;105(3):264-72
pubmed: 20627878
Front Neurosci. 2018 Aug 27;12:591
pubmed: 30210276
BMC Nephrol. 2015 Oct 29;16:176
pubmed: 26510510
Kidney Int. 2002 Dec;62(6):1921-32
pubmed: 12427117
Int Urol Nephrol. 2003;35(3):415-21
pubmed: 15160550
Eur Heart J. 2018 Jun 1;39(21):1883-1948
pubmed: 29562304
Front Physiol. 2017 Mar 27;8:163
pubmed: 28396638
Int Urol Nephrol. 2017 Nov;49(11):1989-1997
pubmed: 28229311
BMC Nephrol. 2013 Oct 16;14:224
pubmed: 24131569
Br J Anaesth. 2012 Feb;108(2):202-10
pubmed: 22171358
Neth J Med. 2014 Dec;72(10):509-15
pubmed: 26219755
Clin Nephrol. 2008 Sep;70(3):210-9
pubmed: 18793562
Eur Heart J. 2000 Sep;21(18):1522-9
pubmed: 10973766
PLoS One. 2018 Dec 6;13(12):e0208127
pubmed: 30521545
Comput Biol Med. 1998 Mar;28(2):121-42
pubmed: 9684089
J Am Soc Nephrol. 2007 Nov;18(11):2960-7
pubmed: 17942958
JAMA Intern Med. 2014 Apr;174(4):588-95
pubmed: 24567036
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
J Intern Med. 2017 Dec;282(6):468-483
pubmed: 28564488
Clin Kidney J. 2014 Jun;7(3):257-63
pubmed: 25852886
Am J Epidemiol. 1993 Feb 1;137(3):342-54
pubmed: 8452142
Nephrology (Carlton). 2017 Mar;22(3):220-227
pubmed: 26890468
J Am Geriatr Soc. 2005 Sep;53(9):1618-22
pubmed: 16137297
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
J Sports Sci. 2015;33(18):1902-7
pubmed: 25805155
Am J Kidney Dis. 2014 Sep;64(3):383-93
pubmed: 24913219
Med Sci Sports Exerc. 2017 May;49(5):1022-1028
pubmed: 28410327
Am J Physiol Regul Integr Comp Physiol. 2001 Mar;280(3):R744-51
pubmed: 11171653
Cardiovasc Res. 1990 Mar;24(3):214-21
pubmed: 2346955
BMC Geriatr. 2015 Dec 24;15:174
pubmed: 26703012
Physiol Meas. 2015 Apr;36(4):741-53
pubmed: 25798657
Clin J Am Soc Nephrol. 2006 Nov;1(6):1197-204
pubmed: 17699348
Am J Kidney Dis. 2015 Oct;66(4):689-98
pubmed: 26209542
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Am J Nephrol. 2015;42(2):134-40
pubmed: 26381744
Sports Med. 2010 Dec 1;40(12):1055-74
pubmed: 21058751
Scand J Med Sci Sports. 2000 Apr;10(2):58-67
pubmed: 10755275
Int Urol Nephrol. 2007;39(1):275-9
pubmed: 17318349
Clin Exp Nephrol. 2018 Feb;22(1):167-172
pubmed: 28634773
J Hypertens. 2007 Jul;25(7):1421-6
pubmed: 17563564
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
Am J Kidney Dis. 2005 Jan;45(1):148-53
pubmed: 15696454
J Am Coll Cardiol. 2003 Apr 2;41(7):1167-73
pubmed: 12679218
Nephron Clin Pract. 2011;118(3):c278-84
pubmed: 21212691
Adv Ren Replace Ther. 1997 Jul;4(3):234-48
pubmed: 9239428
Phys Ther. 2000 Sep;80(9):896-903
pubmed: 10960937

Auteurs

Tobia Zanotto (T)

Centre of Health, Activity and Rehabilitation Research, School of Health Sciences, Queen Margaret University, Edinburgh, EH21 6UU, UK. TZanotto@qmu.ac.uk.

Thomas H Mercer (TH)

Centre of Health, Activity and Rehabilitation Research, School of Health Sciences, Queen Margaret University, Edinburgh, EH21 6UU, UK.

Marietta L van der Linden (ML)

Centre of Health, Activity and Rehabilitation Research, School of Health Sciences, Queen Margaret University, Edinburgh, EH21 6UU, UK.

Robert Rush (R)

Centre of Health, Activity and Rehabilitation Research, School of Health Sciences, Queen Margaret University, Edinburgh, EH21 6UU, UK.

Jamie P Traynor (JP)

Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK.

Colin J Petrie (CJ)

Department of Cardiology, Monklands Hospital, Airdrie, UK.

Arthur Doyle (A)

Renal Unit, Victoria Hospital, Kirkcaldy, UK.

Karen Chalmers (K)

Renal Unit, Victoria Hospital, Kirkcaldy, UK.

Nicola Allan (N)

Renal Unit, Victoria Hospital, Kirkcaldy, UK.

Ilona Shilliday (I)

Renal Unit, Monklands Hospital, Airdrie, UK.

Pelagia Koufaki (P)

Centre of Health, Activity and Rehabilitation Research, School of Health Sciences, Queen Margaret University, Edinburgh, EH21 6UU, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH